Head and Neck Cancer Trial, Recruiting NCT07225855 Sponsor: City of Hope Medical Center Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07225855
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with head and neck cancer that has not spread to other parts of the body
  • People aged 60 years or older
  • People who are planned to receive radiation treatment aimed at curing the cancer, either on its own or combined with chemotherapy, whether before or after surgery
  • People who have completed at least one geriatric (older adult health) assessment using a specific screening tool called the modified Geriatric 8 (G8) (confirm with trial site)
  • People who are able to read and understand English
  • People who have given written consent to take part in the trial
  • Family members or close friends who are involved in the patient's medical care may also be invited to take part, though this is not required — patients without a family caregiver are still eligible
  • Family caregivers who wish to participate must be aged 18 or older and able to read and understand English

Who may not be able to join:

  • There are no specific exclusion criteria listed in the source document (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 July 2026
Est. completion
24 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of grade 2-5 non-hematologic treatment-related toxicities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov